Takikawa H, Sano N, Aiso M, Takamori Y, Yamanaka M
Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
J Gastroenterol Hepatol. 1997 Jan;12(1):84-6. doi: 10.1111/j.1440-1746.1997.tb00352.x.
The effect of tauro-beta-muricholate (beta MC-tau) and tauro-alpha-muricholate (alpha MC-tau) on oestradiol-17 beta-glucuronide (E217G)-induced cholestasis was compared with that of tauroursodeoxycholate (UDC-tau) in rats. Like UDC-tau, alpha MC-tau and beta MC-tau infused at the rate of 0.2 mumol/min per 100 g bodyweight (BW) completely inhibited the cholestasis induced by E217G infused at the rate of 0.06 mumol/min per 100 g BW for 20 min. These findings indicate that beta MC-tau and alpha MC-tau are useful in protecting against various types of experimental cholestasis, as well as against bile acid-induced cholestasis.